The state government has established a partnership with federal authorities to restart the production of common medications, including Panadol and antimalarial drugs. Dr. Oshiomhole confirmed that the pharmaceutical initiative would be incorporated into the state’s 2026 annual plan and upcoming financial strategies.
The revival of local drug manufacturing represents a significant step toward achieving the administration’s campaign promise of providing affordable and accessible healthcare for Edo State residents, while potentially serving as a medical supply hub for the broader South-South region.
Leave a Comment